| 摘要 |
The present invention relates to a method for determining or making of a prognosis if a patient has cancer or is at an increased risk of having cancer, the method comprising testing for the presence of one or more cancer-associated fusion genes, or proteins derived thereof, in a sample obtained from a patient. More specifically, the present invention relates to fusion genes CLEC16A-EMP2, SNX2-PRDM6, MLL3-PRKAG2, DUS2L-PSKH1 and CLDN18- ARHGAP26 in gastric cancer. Use of the method and a kit when used in the method are also provided. |
| 申请人 |
AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH;NATIONAL UNIVERSITY OF SINGAPORE |
发明人 |
HILLMER, AXEL;RUAN, YIJUN;YAO, FEI;TAN, PATRICK;YEOH, KHAY GUAN;HUNZIKER, WALTER;TEO, AUDREY S M;SIA, YEE YEN |
